Medicine

FDA Orders Labeling Changes For Certain Cough And Cold Medicines

FDA Orders Labeling Changes For Certain Cough And Cold Medicines

FDA is requiring safety labeling changes for prescription cough and cold medicines containing codeine or hydrocodone to limit the use of these products to adults 18 years and older because the risks of these medicines outweigh their benefits in children younger than 18.

In addition to limiting use in children following a comprehensive assessment of the risks and benefits of these products, labelling for adult-only use of prescription opioid cough and cold medicines that contain codeine or hydrocodone will also now include updated safety information.

"It's become clear that the use of prescription, opioid-containing medicines to treat cough and cold in children comes with serious risks that don't justify their use in this vulnerable population", he said. The panel declared that the risks of using certain opioids in children's cough medications outweigh the benefits. The warning will notify people the risks of misuse, abuse, addiction, overdose, and death. If the medicine prescribed for your child contains an opioid, talk to your child's health care professional about a different, non-opioid medicine, or if you have any questions or concerns.

It is important for parents and caregivers to understand that a cough due to a common cold often does not need medicines for treatment. "It's critical that we protect children from unnecessary exposure to prescription cough medicines containing codeine or hydrocodone".

Now, the FDA's latest action to revise safety labeling on some prescription cough and cold products expands the pediatric restrictions that were previously in place.

They go much further than the 2017 labeling rules - restricting use of codeine-containing products to everyone under the age of 18, and including cough-and-cold products that contain a second drug, the opioid oxycodone.

Ryman Hospitality Properties (RHP) Upgraded to Buy by Bank of America
Following the transaction, the senior vice president now owns 7,764 shares in the company, valued at approximately $540,607.32. Mangrove Partners increased its position in shares of Ryman Hospitality Properties by 13.4% in the third quarter.

Parents whose children are now prescribed a cough and cold medicine containing codeine or hydrocodone are encouraged to talk to their child's health care professional about other treatment options, the FDA advised.

Common side effects of extended opioid use include drowsiness, dizziness, nausea, vomiting, constipation, shortness of breath and headache.

One physician who's dealt with the aftermath of opioid overuse applauded the move. The federal directive also said mothers who are breast-feeding should not take the medications because the opioids could get passed on to their babies while nursing.

"The opioid epidemic has many origins, but can begin with exposure to [opioids] at young ages", he said.

According to the agency, outside experts said that while some children's coughs require treatment, many get better on their own _ including ones that are the result of respiratory infections. Always read the labels on prescription bottles.

The FDA also says the new changes are " based on an extensive review of available data and expert advice shared at meetings to explore the pediatric use of opioid-containing cough and cold products".


  • ADP reveals how APC will rig elections

    ADP reveals how APC will rig elections

    It does appear to APC that they must re-worked every structure in this country to suit parochial ethnic tendencies and religious tendencies.
    Kings' Frank Mason sidelined at least through January with heel injury

    Kings' Frank Mason sidelined at least through January with heel injury

    He's out 4-to-6 weeks from that December 31st date, which means that he'll return near the end of the month, at the earliest. He would be re-evaluated one week later, ultimately leading to the team's announcement on Thursday.

    Q3 Sentiment Cognizant Technology Solutions Corp (NASDAQ:CTSH)

    Breakiron-Evans Maureen also sold $862,011 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) on Monday, August 7. Cognizant Technology Solutions Corporation's ROI is valued at 12.80% relatively measuring the profitability on the investment.
  • Alex Smith added to AFC Pro Bowl roster

    Alex Smith added to AFC Pro Bowl roster

    Smith joins running back Kareem Hunt, wide receiver Tyreek Hill and tight end Travis Kelce to represent the Chiefs. All three Pro Bowl noms have come in his five season tenure with the Chiefs, including his first season in 2013.

    Lockheed Martin Corp Stock in 2017 Q3 Driven by Institutional Investors

    Lockheed Martin Corporation is a security and aerospace company. 2,873 were accumulated by Univest Corporation Of Pennsylvania. The stock of Lockheed Martin Corporation (NYSE:LMT) has "Buy" rating given on Thursday, October 22 by Argus Research.

    Finance (ARI) Stock Price

    Now we see the performance from the period beginning the first day of the current calendar or fiscal year up to the current date. Traders may use these levels to help identify stock price reversals. (NYSE: ARI ) are dropping -0.65% to traded at $18.22.
  • Analyst Opinion Summary: American Airlines Group Inc. (AAL), Boise Cascade Company

    Analyst Opinion Summary: American Airlines Group Inc. (AAL), Boise Cascade Company

    Citigroup reissued a "buy" rating on shares of American Airlines Group in a research report on Wednesday, September 13th. Carroll Finance reported 19 shares. (NASDAQ: AAL ) shares have climbed higher recently touching a new 52-week peak.
    NYC Sues Fossil Fuel Industry over Hidden Costs of Climate Change

    NYC Sues Fossil Fuel Industry over Hidden Costs of Climate Change

    The lawsuit links global warming to extreme temperatures, severe snowfall, risen sea levels, and more flooding across the state. New York, the birthplace of the nation's annual climate march, has problems.
    DTE Energy (NYSE:DTE) Stock Rating Reaffirmed by Guggenheim

    DTE Energy (NYSE:DTE) Stock Rating Reaffirmed by Guggenheim

    It turned negative, as 40 investors sold AYI shares while 132 reduced holdings. 20 funds opened positions while 41 raised stakes. Following the completion of the sale, the chairman now owns 83,000 shares in the company, valued at approximately $9,373,190.
  • Ignyta, Inc. (RXDX) — Trend Analysis Report

    Oppenheimer maintained the stock with "Buy" rating in Friday, August 4 report. "Stock Is Soaring Today" on December 22, 2017. Barclays Public Limited Com, United Kingdom-based fund reported 26,109 shares. 129,968 are owned by Ameriprise Fincl Inc.

    Credit Suisse Group Initiates Coverage on Energy Transfer Equity (NYSE:ETE)

    Currently, the stock carries a price to earnings ratio of 17.21, a price to book ratio of 0, and a price to sales ratio of 0.51. The stock of Energy Transfer Equity, L.P. (NYSE:ETE) has "Equal-Weight" rating given on Thursday, September 29 by Stephens.

    Drone Footage Shows Muddy 101 Freeway in California

    The Santa Barbara Airbus modified schedule will remain in effect until US Highway 101 has been officially reopened by authorities.